© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
The story of puromycin dihydrochloride stretches back to the golden era of antibiotic discovery in the mid-20th century, at a time when scientists crisscrossed the world in search of new ways to treat infections. Researchers isolated puromycin from a strain of Streptomyces alboniger, recognizing quickly that it could break the protein-making machinery in cells. Chemists analyzed its structure, logistics teams found ways to purify it in bulk, and the compound started making waves in molecular biology labs. From treating infections in its earliest days, puromycin turned into a spearhead for uncovering the hidden rules of biology as a protein synthesis inhibitor. The shift from clinical hopes to research focus gave it a second act. This twist highlights a lesson in science: not every discovery goes in a straight line, but each can find new purpose over time.
At its core, puromycin dihydrochloride disrupts protein synthesis. The compound slips into the ribosome's A site and mimics the end of a growing polypeptide chain, forcing the process to halt and new proteins to abort. Its simple design makes it an essential research tool. Scientists use it for everything from selecting genetically modified cells to studying the basics of translation inside living cells. Whether in powder or solution, puromycin dihydrochloride gets packed in small vials, often requiring storage at cold temperatures to protect its chemical integrity. Depending on the lot, color and form can shift, though the underlying reactivity stays consistent. The product stands out by making the process of cell selection and protein synthesis interruption quick, sharp, and trackable, especially via tagging or toxicity screens.
Fat, white, or off-white powder. Soluble in water and ethanol. Its molecular formula stands as C22H29N7O5•2HCl, with a weight just above 544 Daltons. Puromycin moves through aqueous solutions with agility, driven by multiple nitrogen-rich rings and sugar groups. Exposure to light or moisture can degrade it, making sealed packaging necessary. Working with puromycin means paying respect to temperature: lower keeps it stable, heat or humidity can cut its shelf life or lead to degradation products. The hydrochloride salt improves solubility, ensuring researchers can rely on consistent performance across a range of research applications.
Product sheets lay out purity, molecular weight, and storage requirements. Most commercial puromycin dihydrochloride clocks in at 98% or better in purity, tested by HPLC or NMR. Each label gives a catalog number, batch code for traceability, and expiry date. Labs rely on the recommended storage temperature, usually -20°C for long-term use. Labels cover hazard warnings and safety data (GHS compliant), with instructions on safe disposal. Exact guidelines differ between suppliers, but key details include the product’s intended use in research, and regular confirmation by independent testing that the material meets the published specs.
The main route to puromycin dihydrochloride involves culturing Streptomyces alboniger in nutrient-rich media under controlled fermentation. Fermentation conditions like pH, oxygen, and temperature have been tuned over decades to coax higher yields. Scientists harvest the fermentation broth, extract the crude antibiotic, and purify it using column chromatography. Chemical conversion to the hydrochloride salt comes next, often by adjusting pH with hydrochloric acid before solvent precipitation. Newer routes involve semi-synthetic tweaks or biosynthetic engineering, but the classic fermentation pathway dominates. The final dry powder undergoes rigorous quality control to confirm purity, potency, and the absence of unwanted byproducts.
Puromycin holds a reactive amino group and a nucleoside core, serving as a base for various modifications. Chemists graft fluorescent tags, biotin, or radioactive isotopes, creating powerful tools for tracking protein synthesis in live and fixed cells. Clever chemists have drawn up analogs and derivatives designed to tune toxicity or facilitate conjugation to resins and microparticles. Each alteration requires strict monitoring to ensure the new form maintains biological activity. Beyond simple conjugation, researchers sometimes tweak the sugar ring or the peptide bond, exploring structure-function relationships or even designing prodrugs for test tube experiments. These modifications open new applications: not only for labeling but for targeted delivery and enhanced specificity in cell-based assays.
Puromycin dihydrochloride goes by many names. Some call it hydroxyphenylalanyl-aminonucleoside hydrochloride, others know it as Puro, or NSC-3056. Each supplier brands it with their own catalog code, though the underlying compound remains the same. Scientists see little difference regardless of supplier-provided label, as long as the lot meets technical requirements. The key is transparency in naming, so labs know exactly what sits in the bottle — and can match literature results or ensure regulatory compliance for their projects.
Puromycin dihydrochloride calls for meticulous handling. Accidental exposure can spark toxicity, especially through skin or inhalation. Lab teams lean on proper PPE: gloves, goggles, and, in open settings, fume hoods. Spills prompt immediate cleanup with proper decontaminants and alert to waste management protocols. Each facility keeps an MSDS on hand; staff receive training in handling hazardous chemicals. Waste disposal follows strict municipal or institutional rules to avoid environmental contamination or human exposure. Regular audits and compliance checks make sure workers and the environment stay protected throughout handling and disposal. Automation and closed systems in major research centers often reduce human contact, adding another layer of safety.
Research uses for puromycin dihydrochloride stretch far. In molecular biology, labs deploy it to select mammalian cells expressing the pac gene, which breaks down puromycin and lets those cells survive. Only genetically modified cells live, transforming clone screening into a fast, reliable process. Puromycin’s role in studying protein synthesis opened up new discoveries in the life sciences, with applications in ribosome profiling and translation tracking. Drug discovery screens turn to puromycin to probe cellular pathways and test new compounds for on-target effects. Some teams attach it to tracers, creating tools to monitor protein turnover in real time. Its ability to stall ribosomes forms the backbone of techniques like puromycin labeling, where scientists gain detailed readouts of where and when new proteins are made. Each use case drives the demand for consistency and quality at every step — from manufacture to lab freezer.
Development in this space shows a pattern: keen focus on refining puromycin derivatives for expanded applications, plus tighter controls on synthesis for cleaner product. Researchers test a spectrum of analogs, uncovering promising avenues like more selective selection markers or less toxic alternatives. Ongoing investment aims to drop costs of production by leveraging genetically engineered strains or improved fermentation regimes. Teams at academic institutes and biotech firms collaborate on open protocols, using puromycin-mediated systems for protein engineering or gene editing. Bioinformaticians pull in big data from genome screens, pairing puromycin selection with cutting-edge sequencing and transcriptomics for deeper insights into disease and cellular function.
Puromycin displays a potent mode of action — its broad capacity to arrest translation means toxicity can emerge fast. Early clinical studies abandoned its use as a human drug after nephrotoxicity and other adverse effects became clear. Toxicologists cataloged dose-response curves and mapped organ targets. Modern labs use very low concentrations for cell selection, but maintain strict exposure protocols. Animal studies continue to examine long-term effects, drawing boundaries between safe research use and clinical risk. Documentation stresses that all use remains firmly within the domain of cell culture and preclinical research, not for therapies or human consumption. Ongoing work looks for ways to use less toxic versions or combinations that spare non-target cells, learning from the basic biology of how cells handle stress and misfolded proteins.
Looking forward, demand for streamlined selection methods and powerful molecular probes will only grow. Labs want faster, cleaner tools to work through massive gene editing projects or patient-derived cell libraries. Synthetic biology could introduce engineered puromycin analogs with built-in safety switches or traceability tags. Multiplex applications may allow one experiment to use puromycin variants for tracking, selection, and functional labeling in the same batch of cells. Increased automation in biotechnology facilities could synchronize puromycin selection with high-throughput platforms, speeding up drug screens and protein engineering. The ongoing hunt for lower-toxicity derivatives keeps the door open for innovative solutions, making puromycin dihydrochloride a mainstay in basic and applied research alike — and a case study in how a single discovery can evolve to meet the complex needs of modern science.
Puromycin dihydrochloride shows up in research labs across the world, tucked inside freezers and ready to play its part in cell biology experiments. Scientists use it to stop protein synthesis dead in its tracks, which lets them test how genes work or confirm that their genetic engineering was successful. That little bottle carries a big punch, and it’s woven into the stories of thousands of discoveries in genetics and cancer. Puromycin’s core appeal is simple: its ability to shut down the making of proteins by slipping into growing chains, causing them to fall apart. Researchers harness this effect when working with cells that carry special resistance genes, helping them spot and keep only the cells they want.
In my lab days, I watched scientists use puromycin to whittle down crowds of cells to a handful of survivors. They’d introduce a bit of DNA into cells—maybe a new gene, maybe a reporter to watch processes light up under the microscope. After a day or two, a splash of puromycin wiped out any cell not carrying the resistance gene. This approach saves precious time and resources compared to older, slower methods. It weeds out background noise and clears a path for pure, reliable results. Often, the difference between a publication-ready experiment and a messy dud comes down to successful selection.
This chemical helped shape everything from stem cell studies to the hunt for new cancer treatments. Without effective ways to pick out transformed cells, gene editing would slog along, and large-scale screenings for new drugs would stall. Puromycin speeds up these steps. Scientists can explore what happens as DNA changes or trace the roots of disease. Drug developers rely on this power, honing in on promising cells or compounds for therapies that might one day save lives.
The same sharp edge that makes puromycin useful also warns of danger. It kills cells quickly, which means slip-ups in concentration or exposure time ruin weeks of careful work. Sometimes, resistance genes don’t take, or cells change after many rounds of selection. Users need a steady hand and good protocols. Overuse—especially if handled without proper care—can let rogue versions of resistance genes slip outside controlled settings. Biosecurity deserves more attention, especially with genetic tools spreading far beyond top research centers.
Every powerful research tool brings responsibility. Institutes should back tight training and oversight to make sure puromycin does what it’s meant to and nothing more. Documentation habits could improve, so experiments stay traceable, and results stay trustworthy. Safer storage and handling practices, whether through locked cabinets or regular inventories, can cut preventable accidents or misuse. Suppliers can step up by updating safety data and sharing best practices. Researchers should talk through their methods, not glossing over the difficulties, for the good of the science community.
Puromycin dihydrochloride carves out its relevance year after year. Its role in shaping genetic and drug discovery is hard to ignore. Researchers can chase complex questions and bring new treatments closer to real patients. Responsible use doesn’t slow science—it keeps wins genuine, safe, and shared by all. That’s something worth protecting.
Puromycin Dihydrochloride often takes center stage in cell biology research. I remember my own days in a busy research lab, where I learned the hard way that improper storage can ruin a good batch, costing both money and progress. This antibiotic, used for selecting and maintaining genetically modified cells, demands respect in handling and storage.
Temperature plays a big role in keeping puromycin effective. Most suppliers suggest keeping the powder at -20°C or colder. At these temperatures, the product keeps its potency for a long time—often several years. Warm conditions push degradation and can render the antibiotic useless. I’ve seen enough experimental failures caused by a simple forgotten cryovial left out overnight.
Storing puromycin solutions requires a different approach. Water-based solutions break down faster, even at low temperatures. A working solution at 4°C keeps for a few weeks, but for anything longer it belongs at -20°C. Freezing extends the useful life of your stock and avoids repeated freeze-thaw cycles which chip away at stability.
Puromycin degrades in direct contact with light and moisture. Always keep vials tightly sealed and shielded from direct light. Labs often use aluminum foil to wrap sensitive reagents, and it’s no different here. Desiccants inside storage boxes can pull extra moisture away, adding a second line of defense.
It sounds basic, but clear labeling cuts down on mix-ups and keeps researchers safe. A date of preparation, concentration, and initials go a long way. Mislabeling leads to confusion and the use of the wrong solution at a crucial step.
Puromycin Dihydrochloride in powder form survives much longer compared to dissolved solutions. I always draw out only what’s needed, closing the bulk container quickly. Open bottles collect water from humid air, slowly contaminating the stock. For solutions, using sterile techniques and small aliquots keeps the parent stock pure. A personal freezer space helps, especially in student-heavy labs known for mystery spills.
Thawing only what’s needed and using single-use aliquots reduces the risk of cross-contamination. Repeated thawing can be a silent killer—some compounds relax after a freeze, puromycin shows no mercy. Every extra cycle picks at the molecule, shortening its effective life.
Compromised puromycin weakens selection pressure, blurring results. The expense multiplies as failed cultures chew up supplies and time. Antibiotic resistance in cell lines grows if sub-potent antibiotic hangs around too long, risking entire experiments. Reputable suppliers and decades of experience have hammered home these warnings.
Stay organized: split up stock into labeled, single-use vials. Use an inventory sheet—better yet, a digital inventory if possible. Routinely check expiration dates and disposal logs. Train new lab members on proper handling, because even the best policy fails if ignored on a busy afternoon.
Puromycin Dihydrochloride rewards careful storage with consistent performance. Anyone chewing through grant money learns quickly that protecting reagents’ quality builds a foundation for success down the line.
Anyone who’s spent time hunched over a cell culture hood knows the headache of cell selection. You want surviving cells and only the right ones, no more, no less. Puromycin dihydrochloride often shows up on the bench when it’s time to select for transfected or stably expressing cells. Still, plenty of folks ask: how much do I add for solid results? There’s more to this than copying a protocol from a typical methods section.
Most published recommendations suggest starting with 1–10 μg/mL for mammalian cells. It’s easy to say, “Just use 2 μg/mL and go,” but that glosses over why this drug works like it does. Puromycin kills quickly by blocking protein synthesis, but sensitivity varies across cell types. An immortalized human cell line like HEK293 might fall apart within 48 hours at 2 μg/mL, but primary mouse neurons may resist for days at a higher dose. Dozens of labs have posted firsthand accounts warning against using a neighbor’s recipe blindly, only to see wild results.
Experienced cell biologists run a kill curve before settling on a working concentration. Take a handful of wells, load each with a different amount—maybe 0.5, 1, 2, 5, 8, 10 μg/mL. Check daily for dead cells and floating debris. The lowest dose that wipes out every unprotected cell in under a week gets the thumbs up. An old mentor once put it bluntly: “If you don’t do a kill curve, don’t blame the cells for outgrowing your antibiotic.” That lesson stuck.
Every batch of FBS or media brings new quirks. Cells stressed before drug selection act more fragile and die off at lower doses. Different lots of puromycin might have small potency shifts because of storage or manufacturer changes. These quirks matter. A fresh bottle might seem “hotter” or “weaker” than a last one. Keeping a written log with concentration and date helps sidestep nasty surprises, especially when training new lab members.
Get the concentration wrong, and you end up nurturing survivors that aren’t truly resistant. One student in my lab once used an old, diluted stock by mistake—every plate looked fine for weeks, but the clones failed to express their gene of interest under stress. Months of work gone. The cost of a good titration up front pales in comparison.
Every new plasmid or cell line deserves its own titration. Make it routine. Standardize as much as possible, from cell density at seeding to media changes. Share data across teams so no one starts from zero. If a group down the hall found 1.25 μg/mL wipes out HeLa cells by day three, that’s a strong clue. Taking a few extra days for a careful kill curve saves more time later and produces reliable cell populations.
Bottom line: There’s no silver bullet. You can use published ranges as a guide, but taking the time to test and record what works for each project builds more dependable results—and much less stress down the road.Anybody working in cell biology knows the push and pull with antibiotics like puromycin dihydrochloride. It’s a sort of hero and villain in the same breath. Researchers rely on it because of its ability to kill cells fast, which comes in handy for those selection experiments where only resistant cells should survive. The catch is, this rapid action signals just how toxic it can get — especially for mammalian cells.
Puromycin’s trick is that it pretends to be a part of the normal protein-building toolkit inside the cell. During translation, it sneaks into ribosomes and causes the protein assembly line to grind to a halt. Any cell that can’t break down or pump out puromycin ends up collapsing. For most mammalian cells, even low concentrations spell trouble. Studies have shown that doses as low as 1–10 micrograms per milliliter wipe out cultures in less than two days. That kind of potency isn’t a coincidence; researchers use puromycin because it leaves only the genetically modified survivors intact.
Working with mammalian cells for several years, I’ve learned to respect puromycin’s punch. The smallest miscalculation in concentration leads to an empty flask the next morning. This is not some mild discomfort for the cells; it’s swift and fatal. Every time I’ve set up a selection, it’s a balancing act. Too little and the unmodified cells slip through, too much and even the intended lines can’t make it.
Facts back up this cautious approach. Literature points to how quickly puromycin disrupts protein synthesis, triggering apoptosis — sometimes within a few hours. In human cell lines like HEK 293 or HeLa, classic concentrations kill almost everything not engineered for resistance. There’s no gentle warning, only a clean sweep.
It’s tempting for newcomers to see antibiotics like puromycin just as technical tools. In practice, they force hard decisions. The toxicity to mammalian cells doesn’t just weed out the weak; it shapes which lines survive long enough to get analyzed. There’s also the waste factor — one false step and days or weeks of work flush away, cells down the drain.
Concern about overuse is real. Sometimes labs depend on antibiotic selection instead of finding more reliable gene delivery systems. Pressuring cells to survive constant toxin exposure can introduce side effects. Cells adapt in surprising ways under stress, and sometimes these changes shape results quietly in the background.
Instead of using the maximum possible dose, smart labs take the time to test each new batch and cell line for sensitivity. Small titration experiments, a bit of patience, and plenty of observation make the difference between useful data and wasted effort. Workarounds like using lower concentrations with longer selection times can give more reliable results and reduce cell stress. There’s wisdom in the old lab saying: do the small experiment first, avoid the big mess later.
New solutions could help labs rely less on brute force. More specific gene editing and delivery systems, better markers, and culture conditions that boost cell health should be priorities. For now, though, everyone in the field works with one fact in mind: puromycin dihydrochloride pulls no punches. Handle it with care, especially in experiments with mammalian cells. Safety measures for researchers also matter, since puromycin absorbed through the skin or by inhalation poses health risks. Gloves, masks, and careful disposal remain standard practices for a good reason.
Walking into any cell culture room, you can almost sense how a single small error derails weeks of hard work. Sometimes, success or failure hinges on how you mix one reagent. Puromycin Dihydrochloride works as an antibiotic. Scientists use it to select cells carrying a certain resistance, helping to purify cell populations quickly. From my bench experience, a well-prepared stock saves time, protects your experiments, and keeps your results honest.
First thing you want to do: check the powder for clumping, discoloration, or weird smells. Puromycin should appear as a white, fine powder. Sometimes, batches turn sticky if moisture sneaks in. If the bottle looks suspicious, question the quality before trusting your projects to it.
Start with double-distilled water or sterile-filtered water, since most cell lines respond best to this. Some labs go straight to PBS, but water avoids the risk of extra ions messing with solubility. Labs use concentrations like 10 mg/mL or 25 mg/mL, depending on the kill curve for their specific cells. Check your own cell line data, don’t just copy recipes blindly.
Weigh your powder with a clean spatula. Even small spills cost money and throw off your concentrations. Measurement accuracy matters: if you measure 10 mg for a 1 mL solution, add a fraction less or more and your experiments won’t behave the way you planned. Dissolve slowly—just turning the tube gently dissolves puromycin fast. Don’t vortex too roughly, as that introduces air and can denature the substance.
Filter the solution through a 0.22 μm sterile syringe filter straight into a pre-labeled sterile tube. Skipping this step increases the risk of microbial contamination. Nobody wants to find fuzzy colonies in the selection plate or deal with unexplained cell death. Mark the tube with concentration, date, and your initials. It sounds basic, but countless labs have lost essential data because of mislabeled stock.
Store at –20°C. Some researchers break the solution into single-use aliquots to avoid freeze-thaw cycles. Every time you thaw puromycin, you push it closer to degradation. Those tiny freeze-thaws build up, changing the solution’s power and making your results repeat inconsistently.
Don’t forget about toxicity. Puromycin stops protein synthesis, so you don’t want it on your hands or in your eyes. Always wear gloves, a lab coat, and goggles during weighing and dissolving. Discard any waste according to your institution’s chemical safety guidelines. Puromycin runoff can harm aquatic life, so never dump excess down the drain.
Solid preparation habits separate a clean experiment from a frustrating mess. I’ve seen colleagues lose months to ambiguous selection because they skipped careful measurements or filtered too late. Making a strong stock solution means checking every step. You’re not only protecting your own experiment but doing justice to the time and funding supporting your work. If every person in the lab follows these core routines, the research moves forward for everyone.
| Names | |
| Preferred IUPAC name | (2S)-2-(Aminoacetamido)-N-[(2R,3S,4R,5S)-3,4-dihydroxy-5-(6-methoxy-7-methyl-1,4-dihydro-3,4-dioxo-2H-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)oxolan-2-yl]propanamide dihydrochloride |
| Other names |
Puromycin dihydrochloride hydrate Puromycin 2HCl Puromycin hydrochloride NSC 3053 Streptomyces alboniger antibiotic Puro |
| Pronunciation | /ˌpjʊə.rəˈmaɪ.sɪn daɪ.haɪ.droʊˈklɔː.raɪd/ |
| Identifiers | |
| CAS Number | 58-58-2 |
| Beilstein Reference | 3590511 |
| ChEBI | CHEBI:8969 |
| ChEMBL | CHEMBL418472 |
| ChemSpider | 107703 |
| DrugBank | DB00850 |
| ECHA InfoCard | 38ab4f98-38c3-4413-963f-c45a2c7a785b |
| EC Number | 57-63-6 |
| Gmelin Reference | 87846 |
| KEGG | C00733 |
| MeSH | D011689 |
| PubChem CID | 441197 |
| RTECS number | VH8925000 |
| UNII | 55X04QC32I |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | CXT14F2NQ5 |
| Properties | |
| Chemical formula | C22H29N7O5·2HCl |
| Molar mass | 544.31 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | Density: 0.98 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.8 |
| Acidity (pKa) | 7.67 |
| Basicity (pKb) | 7.77 |
| Viscosity | Viscous liquid |
| Dipole moment | 1.96 D |
| Pharmacology | |
| ATC code | J01XX06 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin irritation, causes serious eye irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | 'Pictograms': "GHS06 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332: Harmful if swallowed, in contact with skin or if inhaled. |
| Precautionary statements | P261, P273, P280, P305+P351+P338, P311 |
| Lethal dose or concentration | LD₅₀ (oral, rat): 135 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse (intraperitoneal) 100 mg/kg |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 µg/mL |
| Related compounds | |
| Related compounds |
Puromycin Blasticidin S Geneticin (G418) Hygromycin B Neomycin Streptomycin Paromomycin Genistin |
